COMPARISON OF CLOTRIMAZOLE, FLUCONAZOLE AND ITRACONAZOLE IN VAGINAL CANDIDIASIS
- 1 March 1995
- journal article
- clinical trial
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 49 (2), 65-66
- https://doi.org/10.1111/j.1742-1241.1995.tb09895.x
Abstract
Women attending a genitourinary medicine clinic (n = 229) with mycologically confirmed acute vulvovaginal candidiasis were randomised to receive either clotrimazole (500 mg pessary and 1% cream), fluconazole (150 mg single oral dose) or itraconazole (200 mg bd oral dose for 1 day). Mycological cure rates were 96% in the itraconazole group, 95% in the clotrimazole group, and 83% in the fluconazole group (P = 0.008). The proportion of patients who were clinically cured showed a similar pattern (itraconazole 80%, clotrimazole 80%, fluconazole 62%). This suggests that itraconazole or clotrimazole are more effective than fluconazole in the treatment of acute vaginal candidiasis.This publication has 7 references indexed in Scilit:
- Pharmacological Treatment of Acute Vulvovaginal CandidiasisInternational Journal of STD & AIDS, 1993
- An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practiceInternational Journal Of Clinical Practice, 1990
- A comparison of single‐dose oral fluconazole with 3‐day intravaginal clotrimazole in the treatment of vaginal candidiasisBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Antifungal Drugs in Current Use: a ReviewProceedings of the Royal Society of Medicine, 1977
- Candidal Vaginitis: Natural History, Predisposing Factors and PreventionProceedings of the Royal Society of Medicine, 1977
- Genital Yeast InfectionsBMJ, 1972
- THE PATHOGENICITY OF CANDIDA SPECIES IN THE HUMAN VAGINABJOG: An International Journal of Obstetrics and Gynaecology, 1964